Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Novel management of glioma by molecular therapies, a review article.

Alinezhad A, Jafari F.

Eur J Transl Myol. 2019 Aug 21;29(3):8209. doi: 10.4081/ejtm.2019.8209. eCollection 2019 Aug 2.

2.

Insights into molecular therapy of glioma: current challenges and next generation blueprint.

Rajesh Y, Pal I, Banik P, Chakraborty S, Borkar SA, Dey G, Mukherjee A, Mandal M.

Acta Pharmacol Sin. 2017 May;38(5):591-613. doi: 10.1038/aps.2016.167. Epub 2017 Mar 20. Review.

3.

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

Ascierto PA, Agarwala S, Botti G, Cesano A, Ciliberto G, Davies MA, Demaria S, Dummer R, Eggermont AM, Ferrone S, Fu YX, Gajewski TF, Garbe C, Huber V, Khleif S, Krauthammer M, Lo RS, Masucci G, Palmieri G, Postow M, Puzanov I, Silk A, Spranger S, Stroncek DF, Tarhini A, Taube JM, Testori A, Wang E, Wargo JA, Yee C, Zarour H, Zitvogel L, Fox BA, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2016 Nov 15;14(1):313.

4.

Glioma stem cell research for the development of immunotherapy.

Xu Q, Yuan X, Yu JS.

Adv Exp Med Biol. 2012;746:216-25. doi: 10.1007/978-1-4614-3146-6_17. Review.

PMID:
22639171
5.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
6.

Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.

Chen R, Cohen AL, Colman H.

Curr Treat Options Oncol. 2016 Aug;17(8):42. doi: 10.1007/s11864-016-0418-0. Review.

PMID:
27334978
7.

Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.

Curtin JF, King GD, Candolfi M, Greeno RB, Kroeger KM, Lowenstein PR, Castro MG.

Curr Top Med Chem. 2005;5(12):1151-70. Review.

8.

Immunotherapy for glioma: from illusion to realistic prospects?

Dietrich PY, Dutoit V, Walker PR.

Am Soc Clin Oncol Educ Book. 2014:51-9. doi: 10.14694/EdBook_AM.2014.34.51. Review.

9.

Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy.

Peer E, Tesanovic S, Aberger F.

Cancers (Basel). 2019 Apr 15;11(4). pii: E538. doi: 10.3390/cancers11040538. Review.

10.
11.

Emerging targeted therapies for glioma.

Miller JJ, Wen PY.

Expert Opin Emerg Drugs. 2016 Dec;21(4):441-452. Epub 2016 Nov 14. Review.

PMID:
27809598
12.

SOX2 immunity and tissue resident memory in children and young adults with glioma.

Vasquez JC, Huttner A, Zhang L, Marks A, Chan A, Baehring JM, Kahle KT, Dhodapkar KM.

J Neurooncol. 2017 Aug;134(1):41-53. doi: 10.1007/s11060-017-2515-8. Epub 2017 Jun 15.

PMID:
28620836
13.

Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.

Aberger F, Hutterer E, Sternberg C, Del Burgo PJ, Hartmann TN.

Cell Commun Signal. 2017 Jan 25;15(1):8. doi: 10.1186/s12964-017-0163-4. Review.

14.

Principles of immunotherapy.

Liebelt BD, Finocchiaro G, Heimberger AB.

Handb Clin Neurol. 2016;134:163-81. doi: 10.1016/B978-0-12-802997-8.00010-4. Review.

PMID:
26948354
15.

Novel chemotherapeutics and other therapies for treating high-grade glioma.

Kang JH, Adamson C.

Expert Opin Investig Drugs. 2015;24(10):1361-79. doi: 10.1517/13543784.2015.1048332. Epub 2015 Aug 14. Review.

PMID:
26289791
16.
17.

The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.

Jiao H, Yang B, Guan F, Li J, Shan H, Song L, Hu X, Liang S, Du Y, Jiang C.

Neurol Res. 2011 May;33(4):405-14. doi: 10.1179/016164110X12816242542490.

PMID:
21535940
18.

Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.

Kim JH, Kolozsvary A, Rogulski K, Khil MS, Brown SL, Freytag SO.

Cancer J Sci Am. 1998 Nov-Dec;4(6):364-9.

PMID:
9853135
19.

Targeting immune checkpoints in malignant glioma.

Zhang X, Zhu S, Li T, Liu YJ, Chen W, Chen J.

Oncotarget. 2017 Jan 24;8(4):7157-7174. doi: 10.18632/oncotarget.12702. Review.

20.

[Immunotherapy in brain tumors].

De Carli E, Delion M, Rousseau A.

Ann Pathol. 2017 Feb;37(1):117-126. doi: 10.1016/j.annpat.2016.12.001. Epub 2017 Jan 19. Review. French.

PMID:
28111040

Supplemental Content

Support Center